Literature DB >> 7556227

Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.

M Nakao1, M Tada, K Tsuchimori, M Uekata.   

Abstract

The activities of various types of antiulcer agents against Helicobacter pylori strains were determined by an agar dilution method. Among the compounds tested, benzimidazole proton pump inhibitors were found to have significant activity against this organism. The activity of lansoprazole was fourfold more potent than that of omeprazole and bismuth subsalicylate, with MICs ranging from 1.56 to 25 micrograms/ml. Exposure of Helicobacter pylori to lansoprazole led to an extensive loss of viability as well as suppression of virulence factors such as motility, adhesiveness to epithelial cells and urease activity. The combination of lansoprazole with antimicrobial agents such as penicillins, cephalosporins, macrolides, tetracyclines, aminoglycosides, quinolones, metronidazole and bismuth subsalicylate generally had an additive effect on inhibition of Helicobacter pylori growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556227     DOI: 10.1007/bf02114894

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Clarithromycin and omeprazole for Helicobacter pylori.

Authors:  R P Logan; P A Gummett; B T Hegarty; M M Walker; J H Baron; J J Misiewicz
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

2.  In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.

Authors:  T U Westblom; S Gudipati; B R Midkiff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

3.  In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

Authors:  J A García-Rodríguez; J E García Sánchez; M I García García; E García Sánchez; J L Muñoz Bellido
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Activity of lansoprazole against Helicobacter pylori.

Authors:  F Megraud; L Boyanova; H Lamouliatte
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  Patterns of physical modes of contact between Campylobacter pylori and gastric epithelium: implications about the bacterial pathogenicity.

Authors:  M Caselli; N Figura; L Trevisani; P Pazzi; P Guglielmetti; M R Bovolenta; G Stabellini
Journal:  Am J Gastroenterol       Date:  1989-05       Impact factor: 10.864

6.  Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.

Authors:  K A Eaton; C L Brooks; D R Morgan; S Krakowka
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Authors:  D L Shungu; D R Nalin; R H Gilman; H H Gadebusch; A T Cerami; C Gill; B Weissberger
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

8.  Activity of antibiotics and azole antimycotics against Helicobacter pylori.

Authors:  G von Recklinghausen; C Di Maio; R Ansorg
Journal:  Zentralbl Bakteriol       Date:  1993-09

9.  Characteristics of Helicobacter pylori variants selected for urease deficiency.

Authors:  G I Pérez-Pérez; A Z Olivares; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.

Authors:  J A Armstrong; S H Wee; C S Goodwin; D H Wilson
Journal:  J Med Microbiol       Date:  1987-12       Impact factor: 2.472

View more
  7 in total

1.  In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.

Authors:  T Alarcón; D Domingo; I Sánchez; F Díaz de Rojas; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

2.  Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination.

Authors:  Farideh Siavoshi; Parastoo Saniee; Saman Khalili-Samani; Farideh Hosseini; Fahimeh Malakutikhah; Marzieh Mamivand; Somayeh Shahreza; Amir Houshang Sharifi
Journal:  Ann Transl Med       Date:  2015-01

3.  Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.

Authors:  K Nagata; N Sone; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 4.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

5.  In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.

Authors:  T Alarcón; D Domingo; I Sánchez; J C Sanz; M J Martínez; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Preclinical evaluation of anti-Helicobacter spp. activity of Hippocratea celastroides Kunth and its acute and sub-acute toxicity.

Authors:  Griselda García-Alonso; Antonio Monroy-Noyola; Armando Contreras-Arellano; José Fernando Mariscal-Durand; Yolanda Gálvez-Molina; Alejandro Vázquez-Velázquez; Sara García-Jimenez; Pablo Nuñez; Alexandre Cardoso-Taketa; María Luisa Villarreal
Journal:  BMC Complement Altern Med       Date:  2016-11-08       Impact factor: 3.659

7.  Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others.

Authors:  Masahiko Nakamura; Hidenori Matsui; Hiroshi Serizawa; Kanji Tsuchimoto
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.